Skip to main content
Equibles

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in RAPP — Rapport Therapeutics, Inc.

CIK 1705339 CAUSEWAY BAY, K3
Back to RAPP Full portfolio

Position in RAPP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$587,880
+$161,773 QoQ
Shares Held
14,108
+3.6% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 159 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RAPP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $446,316,962 across 286 Biotechnology names. RAPP ranks #121 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 150,692 $74,853,236
2 REGN
Regeneron Pharmaceuticals, Inc.
 59,595 $37,159,864
3 ALNY
Alnylam Pharmaceuticals, Inc.
 63,265 $19,044,662
4 RPRX
Royalty Pharma plc
 259,390 $14,543,997
5 TWST
Twist Bioscience Corp
 100,108 $10,299,110
6 INCY
Incyte Corp
 83,084 $9,418,401
7 PRAX
Praxis Precision Medicines, Inc.
 27,185 $9,101,265
8 MRNA
Moderna, Inc.
 106,564 $7,462,676

All Filings in RAPP

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $587,880 14,108
2026-03-31 $426,107 13,618
2025-12-31 $401,974 13,249
2025-09-30 $239,174 8,053
2025-06-30 $111,551 9,811
2025-03-31 $99,166 9,887
2024-12-31 $94,110 5,305
2024-09-30 $103,976 5,077